FLGT
Fulgent Genetics Inc.
$22.32
-$0.17(-0.76%)
57
Overall
60
Value
58
Tech
55
Quality
Market Cap
$671.56M
Volume
414.08K
52W Range
$14.57 - $22.87
Target Price
$25.33
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||
| Total Revenue | $18.3M | $18.7M | $21.4M | $32.5M | $421.7M | $992.6M | $619.0M | $289.2M | $283.5M | ||
| Total Revenue | $18.3M | $18.7M | $21.4M | $32.5M | $421.7M | $992.6M | $619.0M | $289.2M | $283.5M | ||
| COST OF GOODS SOLD | |||||||||||
| Cost of Revenue | $-6.7M | $-8.6M | $-10.7M | $14.1M | $89.8M | $215.5M | $252.1M | $184.8M | $176.3M | ||
| GROSS PROFIT | |||||||||||
| Gross Profit | $11.6M | $10.2M | $10.7M | $18.4M | $331.9M | $777.1M | $366.9M | $104.5M | $107.2M | ||
| OPERATING EXPENSES | |||||||||||
| Operating Expenses | $-10.6M | $-13.7M | $-15.7M | $18.8M | $41.7M | $101.1M | $188.4M | $300.0M | $181.1M | ||
| Research & Development | $3.6M | $4.2M | $5.5M | $6.5M | $11.6M | $24.2M | $28.9M | $41.4M | $48.8M | ||
| Research Expense | $3.6M | $4.2M | $5.5M | $6.5M | $11.6M | $24.2M | $28.9M | $41.4M | $48.8M | ||
| Selling, General & Administrative | $7.1M | $9.4M | $10.2M | $26.4M | $120.0M | $75.2M | $150.0M | $130.5M | $124.4M | ||
| Selling & Marketing Expenses | $2.5M | $4.2M | $4.7M | $5.9M | $104.8M | $24.4M | $38.9M | $41.5M | $36.2M | ||
| General & Administrative Expenses | $4.6M | $5.2M | $5.5M | $20.5M | $15.2M | $50.7M | $111.1M | $89.0M | $88.1M | ||
| Salaries & Wages | $-4.7M | $-2.1M | $-2.3M | $-3.2M | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-1.2M | $-1.7M | $-2.2M | $2.1M | $3.0M | $1.7M | $6.5M | $7.8M | $8.0M | ||
| Depreciation & Amortization | $-1.2M | $-1.7M | $-2.2M | $2.1M | $3.0M | $1.7M | $6.5M | $7.8M | $8.0M | ||
| Amortization | -- | -- | -- | -- | -- | $1.7M | $6.5M | $7.8M | $8.0M | ||
| Other Operating Expenses | $-10.6M | $-13.7M | $-15.7M | $18.8M | $-236.0K | $-333.0K | $188.4M | -- | -- | ||
| OPERATING INCOME | |||||||||||
| Operating income | $918.0K | $-3.5M | $-5.1M | $-428.0K | $290.2M | $676.0M | $178.5M | $-195.5M | $-73.9M | ||
| EBITDA | $-3.2M | $-903.0K | $-2.2M | $2.6M | $293.1M | $687.0M | $216.7M | $-141.0M | $-23.4M | ||
| NON-OPERATING ITEMS | |||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | $20.0K | $117.0K | -- | $488.0K | $-170.0K | ||
| Intinc | -- | -- | $434.0K | $837.0K | $1.5M | $1.3M | $5.5M | $21.6M | $31.3M | ||
| Net Non-Operating Interest Income/Expense | -- | -- | $434.0K | $837.0K | $1.5M | $1.3M | $5.5M | $21.1M | $31.5M | ||
| Gain on Sale of Securities | $163.0K | $164.0K | $104.0K | $32.0K | $131.0K | -- | -- | -- | -- | ||
| Other Income/Expense | $5.4M | $524.0K | $935.0K | $777.0K | $488.0K | $-27.9M | $-3.0M | $-320.0K | $-561.0K | ||
| Other Special Charges | -- | -- | $16.0K | $59.0K | $257.0K | $26.4M | -- | $320.0K | $561.0K | ||
| SPECIAL ITEMS | |||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | $3.0M | -- | -- | ||
| Special Income Charges | -- | -- | -- | -- | -- | $-215.5M | $-3.0M | $-120.2M | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $215.5M | -- | $120.2M | -- | ||
| PRE-TAX INCOME | |||||||||||
| EBIT | $-4.5M | $-3.0M | $-4.6M | $409.0K | $290.2M | $676.0M | $184.0M | $-173.6M | $-52.1M | ||
| Pre-Tax Income | $-4.5M | $-3.0M | $-4.6M | $409.0K | $291.7M | $677.3M | $184.0M | $-174.1M | $-52.0M | ||
| INCOME TAX | |||||||||||
| Tax Provision | $920.0K | $-1.0M | $36.0K | $43.0K | $72.5M | $174.8M | $42.1M | $1.2M | $-8.1M | ||
| NET INCOME | |||||||||||
| Net Income | $-5.4M | $-2.5M | $-5.6M | $-411.0K | $214.3M | $507.4M | $143.4M | $-167.8M | $-42.7M | ||
| Net Income (Continuing Operations) | $-5.4M | $-2.5M | $-5.6M | $-411.0K | $214.3M | $507.4M | $141.9M | $-175.2M | $-43.8M | ||
| Net Income (Discontinued Operations) | $-5.4M | $-2.5M | $-5.6M | $-411.0K | $214.3M | $507.4M | $143.4M | $-167.8M | $-42.7M | ||
| Net Income (Common Stockholders) | $-5.4M | $-2.5M | $-5.6M | $-411.0K | $214.3M | $507.4M | $143.4M | $-167.8M | $-42.7M | ||
| TOTALS | |||||||||||
| Total Expenses | $-17.4M | $-22.2M | $-26.4M | $33.0M | $131.6M | $316.6M | $440.4M | $484.7M | $357.4M | ||
| SHARE & EPS DATA | |||||||||||
| Average Shares Outstanding | $13.7M | $17.7M | $18.0M | $18.7M | $22.7M | $29.4M | $30.1M | $29.8M | $30.2M | ||
| Average Shares Outstanding (Diluted) | $107.8M | $17.7M | $18.0M | $18.7M | $24.1M | $31.0M | $31.0M | $29.8M | $30.2M | ||
| Shares Outstanding | $17.7M | $17.9M | $18.3M | $21.6M | $28.9M | $30.3M | $29.5M | $29.8M | $30.8M | ||
| Basic EPS | $0.05 | $-0.09 | $-0.11 | $-0.02 | $9.44 | $17.25 | $4.76 | $-5.63 | $-1.41 | ||
| Basic EPS (Continuing Operations) | -- | $-0.14 | $-0.31 | $-0.02 | $9.44 | $17.25 | $4.76 | $-5.63 | $-1.41 | ||
| Diluted EPS | $0.05 | $-0.09 | $-0.11 | $-0.02 | $8.91 | $16.38 | $4.63 | $-5.63 | $-1.41 | ||
| Diluted EPS (Continuing Operations) | -- | $-0.14 | $-0.31 | $-0.02 | $8.91 | $16.38 | $4.63 | $-5.63 | $-1.41 | ||
| OTHER METRICS | |||||||||||
| Accretion On Preferred Stock | $-4.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Acquired In Process Rn D Income | $-5.4M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Commission Expenses | -- | -- | -- | -- | $89.8M | -- | -- | -- | -- | ||
| Cumulative Effect Of Accounting Change | -- | -- | -- | -- | -- | $239.0K | -- | -- | -- | ||
| Earnings from equity interest | -- | $-524.0K | $-935.0K | $-777.0K | $-488.0K | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | $-524.0K | $-935.0K | $-777.0K | $-488.0K | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | $481.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | -- | -- | -- | -- | $569.4M | $1.1M | $1.5M | $7.4M | $1.1M | ||
| Net Income Discontinuous Operations | $400.0K | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Net Income From Other Gains Losses | -- | -- | -- | -- | $-4.4M | $3.7M | -- | -- | -- | ||
| Other Gand A | $4.6M | $5.2M | $5.5M | $20.5M | $15.2M | $50.7M | $111.1M | $89.0M | $88.1M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | $4.4M | -- | -- | -- | -- | ||
| Other Write Off | $-27.0K | $-24.0K | $-6.0K | $28.0K | $23.0K | $499.0K | -- | -- | -- | ||
| Otherunder Preferred Stock Dividend | $-4.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $-4.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Realized Capital Gain | -- | -- | $434.0K | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $4.6M | $5.2M | $5.5M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $2.5M | $4.2M | $4.7M | $5.9M | -- | -- | -- | -- | -- | ||
| Write Off | -- | -- | -- | -- | -- | $215.5M | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | -- | $3.0M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FLGT | $22.32 | -0.8% | 414.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |